RDF/XMLNTriplesTurtleShow queryShare
SubjectPredicateObject
http://purl.uniprot.org/citations/26387755http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/26387755http://www.w3.org/2000/01/rdf-schema#comment"Acute myeloid leukemia (AML) is driven and sustained by leukemia stem cells (LSCs) with unlimited self-renewal capacity and resistance to chemotherapy. Mutation in the TP53 tumor suppressor is relatively rare in de novo AML; however, p53 can be regulated through post-translational mechanisms. Here, we show that p53 activity is inhibited in inv(16)(+) AML LSCs via interactions with the CBFβ-SMMHC (CM) fusion protein and histone deacetylase 8 (HDAC8). HDAC8 aberrantly deacetylates p53 and promotes LSC transformation and maintenance. HDAC8 deficiency or inhibition using HDAC8-selective inhibitors (HDAC8i) effectively restores p53 acetylation and activity. Importantly, HDAC8 inhibition induces apoptosis in inv(16)(+) AML CD34(+) cells, while sparing the normal hematopoietic stem cells. Furthermore, in vivo HDAC8i administration profoundly diminishes AML propagation and abrogates leukemia-initiating capacity of both murine and patient-derived LSCs. This study elucidates an HDAC8-mediated p53-inactivating mechanism promoting LSC activity and highlights HDAC8 inhibition as a promising approach to selectively target inv(16)(+) LSCs."xsd:string
http://purl.uniprot.org/citations/26387755http://purl.org/dc/terms/identifier"doi:10.1016/j.stem.2015.08.004"xsd:string
http://purl.uniprot.org/citations/26387755http://purl.uniprot.org/core/author"Cai Q."xsd:string
http://purl.uniprot.org/citations/26387755http://purl.uniprot.org/core/author"Liu H."xsd:string
http://purl.uniprot.org/citations/26387755http://purl.uniprot.org/core/author"Li L."xsd:string
http://purl.uniprot.org/citations/26387755http://purl.uniprot.org/core/author"Singh S."xsd:string
http://purl.uniprot.org/citations/26387755http://purl.uniprot.org/core/author"Qi J."xsd:string
http://purl.uniprot.org/citations/26387755http://purl.uniprot.org/core/author"Ho Y."xsd:string
http://purl.uniprot.org/citations/26387755http://purl.uniprot.org/core/author"Lin A."xsd:string
http://purl.uniprot.org/citations/26387755http://purl.uniprot.org/core/author"Kuo Y.H."xsd:string
http://purl.uniprot.org/citations/26387755http://purl.uniprot.org/core/author"McDonald T."xsd:string
http://purl.uniprot.org/citations/26387755http://purl.uniprot.org/core/author"Hua W.K."xsd:string
http://purl.uniprot.org/citations/26387755http://purl.uniprot.org/core/author"Huang W.J."xsd:string
http://purl.uniprot.org/citations/26387755http://purl.uniprot.org/core/author"Marcucci G."xsd:string
http://purl.uniprot.org/citations/26387755http://purl.uniprot.org/core/author"Chang C.I."xsd:string
http://purl.uniprot.org/citations/26387755http://purl.uniprot.org/core/author"Bhatia R."xsd:string
http://purl.uniprot.org/citations/26387755http://purl.uniprot.org/core/author"Chao S.W."xsd:string
http://purl.uniprot.org/citations/26387755http://purl.uniprot.org/core/date"2015"xsd:gYear
http://purl.uniprot.org/citations/26387755http://purl.uniprot.org/core/name"Cell Stem Cell"xsd:string
http://purl.uniprot.org/citations/26387755http://purl.uniprot.org/core/pages"597-610"xsd:string
http://purl.uniprot.org/citations/26387755http://purl.uniprot.org/core/title"HDAC8 Inhibition Specifically Targets Inv(16) Acute Myeloid Leukemic Stem Cells by Restoring p53 Acetylation."xsd:string
http://purl.uniprot.org/citations/26387755http://purl.uniprot.org/core/volume"17"xsd:string
http://purl.uniprot.org/citations/26387755http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/26387755
http://purl.uniprot.org/citations/26387755http://xmlns.com/foaf/0.1/primaryTopicOfhttps://pubmed.ncbi.nlm.nih.gov/26387755